Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoporosis: gender-specific aspects.

Peter Pietschmann1, Katharina Kerschan-Schindl

  • 1Department of Pathophysiology, Medical University of Vienna, Austria. peter.pietschmann@meduniwien.ac.at

Wiener Medizinische Wochenschrift (1946)
|November 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between muscle FNDC5, FGF21 mRNA, miR-150 and bone loss after sciatic denervation.

Journal of physiology and biochemistry·2026
Same author

Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study.

Archives of orthopaedic and trauma surgery·2026
Same author

Effect of the JAK Inhibitor Baricitinib on Cytokine Production and Bone Properties in a Mouse Model of Accelerated Aging.

International journal of molecular sciences·2026
Same author

Effect of alendronate on survival and bone properties in Nothobranchius furzeri: insights from a model of accelerated aging.

Experimental gerontology·2026
Same author

Exercise for fracture prevention - evidence and consensus-based practice guideline of the osteology umbrella association (DVO).

BMC endocrine disorders·2026
Same author

Bone metabolism in primary hyperparathyroidism.

Wiener klinische Wochenschrift·2025
Same journal

Necrotizing fasciitis of the thigh-a devastating sign of intestinal perforation.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Regenerative therapies in rehabilitation with interfaces with occupational medicine, geriatrics, and oncology: the example of extracorporeal shock wave therapy.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Cerebral toxoplasmosis in patients with peripheral B-cell lymphoma : A case series and a literature review.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Post-pandemic rebound of rotavirus and adenovirus in pediatric gastroenteritis: a 6-year antigen-based surveillance study from Turkey.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Neuroaxis involvement in Chikungunya virus infection: a retrospective case series.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

A complicated case of a spinal Scedosporium apiospermum infection with a favorable outcome-case report.

Wiener medizinische Wochenschrift (1946)·2026
See all related articles

Osteoporosis affects men significantly, with estrogen deficiency playing a key role in male bone health. Treatments like alendronate and teriparatide show equal effectiveness in both men and women.

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Men's Health

Background:

  • Osteoporosis is often perceived as a postmenopausal women's disease, but it is a frequent and severe condition in men.
  • Secondary osteoporosis is more prevalent in men than in women.
  • Estrogen is increasingly recognized for its critical role in regulating the male skeleton, similar to its established role in postmenopausal women.

Purpose of the Study:

  • To highlight the significance of osteoporosis in men.
  • To explore the role of estrogen in male osteoporosis pathogenesis.
  • To review current treatment options for osteoporosis in men.

Main Methods:

  • Review of existing literature on male osteoporosis.
  • Analysis of studies investigating serum estradiol levels in men with idiopathic osteoporosis.

Related Experiment Videos

  • Examination of clinical trial data on osteoporosis treatments in men.

    • Main Results:

    • Decreased serum estradiol levels were observed in men with idiopathic osteoporosis.
    • Estrogen deficiency is suggested as a dominant factor in male osteoporosis.
    • Alendronate and teriparatide demonstrated comparable efficacy in treating osteoporosis in men and women.

    Conclusions:

    • Osteoporosis in men is a significant health concern.
    • Estrogen plays a crucial role in male bone health.
    • Established osteoporosis treatments are effective in men, warranting further research and clinical attention.